India's Sun Pharmaceutical has signed an agreement to acquire US biotech Concert Pharmaceuticals and its lead drug deuroxilitinib, in phase 3 testing for alopecia areata, a leading cause of hair loss.

Alopecia areata is considered a common autoimmune condition, so it’s important to know you’re not alone. But it’s easy to feel isolated if you don’t know anyone else who has AA.

Eli Lilly and Incyte's Olumiant has secured the first FDA approval for a systemic drug to treat alopecia areata, an autoimmune condition causing patchy hair loss that affects more than 700,000 ...

Bitcoin Real-Time Candlestick Patterns ... Candlestick Chart 1 5 15 30 1H 5H 1D 1W 1M Loading 1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 5 years Max ...

Hair loss and baldness are more treatable than ever. Learn about hair loss prevention, treatment options for alopecia, male pattern baldness, hair loss in women, and thinning hair in both men and ...